furosemide has been researched along with alprostadil in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Kanai, N; Lu, R; Satriano, JA; Schuster, VL; Wolkoff, AW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chimori, K; Dodo, S; Goi, R; Miura, K; Miyazaki, S; Sakanaka, A | 1 |
| Forder, JR; Gillis, CN; Pitt, BR | 1 |
| Moodie, DS | 1 |
| Berger, R; Frey, B; Hülsmann, M; Ioannides, C; Pacher, R; Stanek, B; Wutte, M | 1 |
| Goldstein, JL; Layden, TJ; Rao, MC; Sahi, J | 1 |
| Doi, K; Kitamura, K; Kubo, T; Mishiro, Y; Okusa, M; Takeda, N | 1 |
| Brauer, RB; Marx, T; Stangl, MJ; Ulm, K | 1 |
1 trial(s) available for furosemide and alprostadil
| Article | Year |
|---|---|
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Life Tables; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 1995 |
15 other study(ies) available for furosemide and alprostadil
| Article | Year |
|---|---|
Identification and characterization of a prostaglandin transporter.
Topics: Amino Acid Sequence; Animals; Antiporters; Base Sequence; Biological Transport; Carrier Proteins; Codon; Colon; DNA-Binding Proteins; DNA, Complementary; Epithelium; HeLa Cells; Humans; Kidney Medulla; Molecular Sequence Data; Organic Anion Transporters; Prostaglandins; Rats; RNA, Messenger; Xenopus | 1995 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Release mechanisms of inactive renin from rat renal cortical slices: role of the submandibular gland].
Topics: Alprostadil; Animals; Enzyme Precursors; Epoprostenol; Furosemide; In Vitro Techniques; Isoproterenol; Kidney Cortex; Male; Rats; Rats, Inbred Strains; Renin; Submandibular Gland | 1990 |
Drug-induced impairment of pulmonary [3H]prostaglandin E1 removal in vivo.
Topics: Alprostadil; Animals; Carbon Radioisotopes; Dextrans; Drug Interactions; Furosemide; Indicator Dilution Techniques; Indocyanine Green; Lung; Male; Probenecid; Prostaglandins E; Rabbits; Tritium | 1983 |
Medical management of infants and children with congenital heart disease.
Topics: Alprostadil; Cardiac Output; Child, Preschool; Digoxin; Furosemide; Heart Defects, Congenital; Heart Failure; Humans; Hypoxia; Infant; Postoperative Care; Prostaglandins E; Tetralogy of Fallot | 1981 |
Cyclic AMP- and phorbol ester-regulated Cl- permeabilities in primary cultures of human and rabbit colonocytes.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Animals; Biological Transport; Bumetanide; Carrier Proteins; Cell Membrane Permeability; Cell Separation; Cells, Cultured; Chlorides; Colforsin; Colon; Cyclic AMP; Fluorescent Dyes; Furosemide; Humans; Indomethacin; Kinetics; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rabbits; Rectum; Sodium-Potassium-Chloride Symporters; Spectrometry, Fluorescence; Time Factors | 1994 |
[Statistical analysis of recovery from sudden deafness among treatment groups].
Topics: Adolescent; Adult; Aged; Alprostadil; Child; Drug Therapy, Combination; Female; Furosemide; Hearing; Hearing Loss, Sudden; Humans; Male; Middle Aged; Steroids; Vitamins | 1996 |
Effect of perioperative administration of a drug regimen on the primary function of human renal allografts.
Topics: Adult; Alprostadil; Cadaver; Diuretics; Dopamine; Female; Furosemide; Graft Rejection; Humans; Intraoperative Period; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Tissue Donors; Transplantation, Homologous | 2010 |